• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVA BIOMEDICAL CORPORATION STATSTRIP; GLUCOSE OXIDASE, GLUCOSE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVA BIOMEDICAL CORPORATION STATSTRIP; GLUCOSE OXIDASE, GLUCOSE Back to Search Results
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Therapeutic Effects, Unexpected (2099); Test Result (2695)
Event Date 05/31/2019
Event Type  No Answer Provided  
Event Description
Patient (pt) had risk factors to do blood sugar (bs) test.Pt's mother was on insulin drip until approx.1 hour before delivery.Bs done with floor glucose monitor @ 1031- 20.1034-22.Pediatrician stated to not treat low bs until she came to assess baby and requested to do serum bs.Glucose gel given to baby as ordered after blood drawn.Results discrepancy noted when comparing blood glucose monitor with serum bs-41 @1110.Mother of infant on insulin drip until 1 hour before delivery, 0930 infant breastfed for 20 minutes, 1030 point-of-care testing (poct) infant blood glucose 20, 1049 called to nurse practitioner (np) to notify of low blood glucose, 1055 np orders serum blood glucose, then treat with oral glucose, 1057 np at bedside to assess infant, 1110 serum blood glucose 41, 1209 transferred to nursery, 1220 poct infant blood glucose 70.The difference in glucose levels is significant, however, some time passed between tests which could have given the infant more time to metabolize the breastmilk and raise its blood glucose as well as more time to regulate its own insulin after delivery, despite the insulin drip its mother was receiving.This is the only instance that has been reported regarding a discrepancy in glucose testing.Suggest continue to monitor for further discrepancies.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STATSTRIP
Type of Device
GLUCOSE OXIDASE, GLUCOSE
Manufacturer (Section D)
NOVA BIOMEDICAL CORPORATION
prospect st
waltham MA 02454
MDR Report Key9990225
MDR Text Key188660704
Report Number9990225
Device Sequence Number1
Product Code CGA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/23/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator No Information
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA04/20/2020
Date Report to Manufacturer04/23/2020
Type of Device Usage N
Patient Sequence Number1
-
-